• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中 dicer 和 drosha 的表达失调。

Dysregulated expression of dicer and drosha in breast cancer.

机构信息

Department of Oncology, First Affiliated Hospital of Zhengzhou University, No. 1, East Jianshe Rd, Zhengzhou, 450003, People's Republic of China.

出版信息

Pathol Oncol Res. 2012 Apr;18(2):343-8. doi: 10.1007/s12253-011-9450-3. Epub 2011 Sep 7.

DOI:10.1007/s12253-011-9450-3
PMID:21898071
Abstract

Large-scale profiling approaches have revealed global down-regulation of microRNAs (miRNAs) in several human cancer types including breast cancer. Altered expression of Dicer and Drosha, two key enzymes in the miRNA maturation, is believed to be one of the most important mechanisms. By using quantitative real-time RT-PCR (QT-PCR), we examined the expression of Dicer and Drosha in 49 pairs of matched human breast cancer tissues. Decreased expression was observed in 53.1% (Dicer), 51.9% (Drosha) and 75.5% (Dicer plus Drosha) breast cancer tissues. In conclusion, the decreased expression of Dicer and Drosha may play a role in down-regulation of miRNAs in breast cancer.

摘要

大规模分析方法显示,包括乳腺癌在内的几种人类癌症类型中的 microRNAs (miRNAs) 呈全球性下调。Dicer 和 Drosha 的表达改变,这两种 miRNA 成熟的关键酶之一,被认为是最重要的机制之一。通过使用定量实时 RT-PCR (QT-PCR),我们检测了 49 对匹配的人乳腺癌组织中 Dicer 和 Drosha 的表达。在乳腺癌组织中观察到 53.1%(Dicer)、51.9%(Drosha)和 75.5%(Dicer 加 Drosha)的表达降低。综上所述,Dicer 和 Drosha 的表达降低可能在乳腺癌中 miRNA 的下调中发挥作用。

相似文献

1
Dysregulated expression of dicer and drosha in breast cancer.乳腺癌中 dicer 和 drosha 的表达失调。
Pathol Oncol Res. 2012 Apr;18(2):343-8. doi: 10.1007/s12253-011-9450-3. Epub 2011 Sep 7.
2
The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.miRNA 加工酶:Drosha 和 Dicer 可预测鼻咽癌的预后。
J Cancer Res Clin Oncol. 2012 Jan;138(1):49-56. doi: 10.1007/s00432-011-1058-1. Epub 2011 Sep 28.
3
Dicer, Drosha, and outcomes in patients with ovarian cancer.Dicer、Drosha与卵巢癌患者的预后
N Engl J Med. 2008 Dec 18;359(25):2641-50. doi: 10.1056/NEJMoa0803785.
4
The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer.Dicer和Drosha在三阴性乳腺癌的配对正常组织、肿瘤及淋巴结转移灶中的表达
BMC Cancer. 2014 Apr 11;14:253. doi: 10.1186/1471-2407-14-253.
5
Complexity in regulation of microRNA machinery components in invasive breast carcinoma.浸润性乳腺癌中微小RNA机制组件调控的复杂性
Pathol Oncol Res. 2014 Jul;20(3):697-705. doi: 10.1007/s12253-014-9750-5. Epub 2014 Feb 27.
6
Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.Argonaute、Dicer 和 Drosha 在浆液性卵巢癌的肿瘤进展过程中上调。
Hum Pathol. 2012 Nov;43(11):2062-9. doi: 10.1016/j.humpath.2012.02.016. Epub 2012 May 29.
7
Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.微小RNA调控因子Drosha、Dicer和Ago2在非小细胞肺癌中的表达
Cell Oncol (Dordr). 2015 Aug;38(4):307-17. doi: 10.1007/s13402-015-0231-y. Epub 2015 Jul 31.
8
Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.微 RNA 加工酶 Drosha 和 dicer 在表皮皮肤癌中的表达水平。
Cancer Invest. 2010 Jul;28(6):649-53. doi: 10.3109/07357901003630918.
9
Down-regulation of Dicer expression in cervical cancer tissues.宫颈癌组织中Dicer表达的下调。
Med Oncol. 2014 May;31(5):937. doi: 10.1007/s12032-014-0937-0. Epub 2014 Mar 28.
10
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.Dicer 和 Drosha 在晚期结直肠癌患者贝伐单抗治疗中的表达及其反应。
Eur J Cancer. 2013 Apr;49(6):1501-8. doi: 10.1016/j.ejca.2012.11.014. Epub 2012 Dec 22.

引用本文的文献

1
Current updates regarding biogenesis, functions and dysregulation of microRNAs in cancer: Innovative approaches for detection using CRISPR/Cas13‑based platforms (Review).癌症中微小RNA的生物发生、功能及失调的最新进展:基于CRISPR/Cas13平台的创新检测方法(综述)
Int J Mol Med. 2025 Jun;55(6). doi: 10.3892/ijmm.2025.5531. Epub 2025 Apr 17.
2
Targeting drug resistance in breast cancer: the potential of miRNA and nanotechnology-driven delivery systems.靶向乳腺癌中的耐药性:微小RNA与纳米技术驱动的递送系统的潜力
Nanoscale Adv. 2024 Nov 12;6(24):6079-6095. doi: 10.1039/d4na00660g. eCollection 2024 Dec 3.
3
AGO2 protein: a key enzyme in the miRNA pathway as a novel biomarker in adrenocortical carcinoma.

本文引用的文献

1
Headway in resistance to endocrine therapy in breast cancer.乳腺癌内分泌治疗耐药的研究进展。
J Thorac Dis. 2010 Sep;2(3):171-7. doi: 10.3978/j.issn.2072-1439.2010.02.03.9.
2
Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium.局部晚期乳腺癌的新辅助治疗:聚焦化疗和生物靶向治疗武器库。
J Thorac Dis. 2010 Sep;2(3):160-70. doi: 10.3978/j.issn.2072-1439.2010.02.03.8.
3
The role of survivin in diagnosis, prognosis and treatment of breast cancer.Survivin 在乳腺癌的诊断、预后和治疗中的作用。
AGO2 蛋白:miRNA 通路中的关键酶,作为肾上腺皮质癌的新型生物标志物。
Endocr Relat Cancer. 2024 Nov 20;31(12). doi: 10.1530/ERC-24-0061. Print 2024 Dec 1.
4
Impacts of (rs10719) and (rs3742330) Variants on Breast Cancer Risk and Their Distribution in Blood and Tissue Samples of Egyptian Patients.(rs10719)和(rs3742330)变体对埃及患者乳腺癌风险的影响及其在血液和组织样本中的分布
Curr Issues Mol Biol. 2024 Sep 12;46(9):10087-10111. doi: 10.3390/cimb46090602.
5
The 3' UTR polymorphisms rs3742330 in DICER1 and rs10719 in DROSHA genes are not associated with primary open-angle and angle-closure glaucoma: As case-control study.DICER1 基因的 3'UTR 多态性 rs3742330 和 DROSHA 基因的 rs10719 与原发性开角型和闭角型青光眼无关:一项病例对照研究。
PLoS One. 2023 Apr 26;18(4):e0284852. doi: 10.1371/journal.pone.0284852. eCollection 2023.
6
MicroRNA expression profiling of endocrine sensitive and resistant breast cancer cell lines.内分泌敏感和耐药乳腺癌细胞系的微小RNA表达谱分析
Biochem Biophys Rep. 2022 Jul 20;31:101316. doi: 10.1016/j.bbrep.2022.101316. eCollection 2022 Sep.
7
APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b.APE1 通过 miR-33a 和 miR-130b 控制 NSCLC 中的 DICER1 表达。
Cell Mol Life Sci. 2022 Jul 25;79(8):446. doi: 10.1007/s00018-022-04443-7.
8
Towards Understanding the Pathogenicity of DROSHA Mutations in Oncohematology.探讨 DROSHA 突变在肿瘤血液学中的致病性。
Cells. 2021 Sep 8;10(9):2357. doi: 10.3390/cells10092357.
9
Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment.肿瘤微环境中 microRNAs 的治疗靶向。
Int J Mol Sci. 2021 Feb 23;22(4):2210. doi: 10.3390/ijms22042210.
10
The Effect of (E)-1-(4'-aminophenyl)-3-phenylprop-2-en-1-one on MicroRNA-18a, Dicer1, and MMP-9 Expressions against DMBA-Induced Breast Cancer.(E)-1-(4'-氨基苯基)-3-苯基-2-丙烯-1-酮对 DMBA 诱导的乳腺癌中 microRNA-18a、Dicer1 和 MMP-9 表达的影响。
Asian Pac J Cancer Prev. 2020 May 1;21(5):1213-1219. doi: 10.31557/APJCP.2020.21.5.1213.
J Thorac Dis. 2010 Jun;2(2):100-10.
4
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
5
Emerging paradigms of regulated microRNA processing.调控 microRNA 加工的新兴模式。
Genes Dev. 2010 Jun 1;24(11):1086-92. doi: 10.1101/gad.1919710.
6
Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.微 RNA 加工酶 Drosha 和 dicer 在表皮皮肤癌中的表达水平。
Cancer Invest. 2010 Jul;28(6):649-53. doi: 10.3109/07357901003630918.
7
miRNAs and cancer: New research developments and potential clinical applications.miRNAs 与癌症:新的研究进展与潜在临床应用
Cancer Biol Ther. 2009 Dec;8(24):2317-22. doi: 10.4161/cbt.8.24.10765. Epub 2009 Dec 30.
8
Breast cancer epigenetics: from DNA methylation to microRNAs.乳腺癌表观遗传学:从 DNA 甲基化到 microRNAs。
J Mammary Gland Biol Neoplasia. 2010 Mar;15(1):5-17. doi: 10.1007/s10911-010-9165-1. Epub 2010 Jan 27.
9
microRNA, cell cycle, and human breast cancer.microRNA、细胞周期与人类乳腺癌。
Am J Pathol. 2010 Mar;176(3):1058-64. doi: 10.2353/ajpath.2010.090664. Epub 2010 Jan 14.
10
Dicer, Drosha, and outcomes in patients with ovarian cancer.Dicer、Drosha与卵巢癌患者的预后
N Engl J Med. 2008 Dec 18;359(25):2641-50. doi: 10.1056/NEJMoa0803785.